Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
1,390.95
-14.85 (-1.06%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 1.35 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,390.95",
    "chg": -14.85,
    "chgp": "-1.06%",
    "dir": -1,
    "prev_price": "1,405.80",
    "mcapval": "6,471.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544319,
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "Sep 21, 03:30 PM",
    "curr_time": "20:42 PM",
    "last_traded_at": "Sep 21, 03:30 PM IST",
    "bse_nse_vol": "1.35 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-4191959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SenoresPharmace_mojoScore_4191959.png",
        "date": "2026-09-13 10:10:33",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Senores Pharmaceuticals Falls 3.73%: Mixed Technicals and Valuation Concerns Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-falls-373-mixed-technicals-and-valuation-concerns-shape-weekly-trend-4183025",
        "imagepath": "",
        "date": "2026-09-05 10:01:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Stock opens at Rs.1,433.05, down 3.33% amid broad market weakness</p>\n                    <p><strong>1 Sep:</strong> MarketsMOJO downgrades Senores Pharmaceuticals to Hold</p>\n                    <p><strong>2 Sep:</strong> Mixed technical signals emerge despite 1.43% intraday gain</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.1,427.10, down 0.37% on final trading day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,482.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..."
      },
      {
        "title": "Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-4179071",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SenoresPharmace_mojoScore_4179071.png",
        "date": "2026-09-02 08:57:08",
        "description": "Senores Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 1 September 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have tempered the overall outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4178820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SenoresPharmace_technicaldot_4178820.png",
        "date": "2026-09-02 08:10:48",
        "description": "Senores Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-4168566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SenoresPharmace_mojoScore_4168566.png",
        "date": "2026-08-25 10:10:49",
        "description": "Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,580 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-stock-hits-all-time-high-amid-robust-financial-performance-4166920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SenoresPharmace_priceRelatedfactors_4166920.png",
        "date": "2026-08-24 10:29:09",
        "description": ""
      },
      {
        "title": "Senores Pharmaceuticals Gains 2.54%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-254-6-key-factors-driving-the-weeks-momentum-4164697",
        "imagepath": "",
        "date": "2026-08-22 10:00:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> New 52-week and all-time high at Rs.1,514</p>\n                    <p><strong>18 Aug:</strong> Further 52-week and all-time high at Rs.1,563</p>\n                    <p><strong>19 Aug:</strong> New 52-week and all-time high at Rs.1,574</p>\n                    <p><strong>20 Aug:</strong> Price correction to Rs.1,515 amid broader market gains</p>\n                    <p><strong>21 Aug:</strong> Week closes at Rs.1,514.65, marginally down</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,546.35</div></div>\n                    <div class=\"stat-..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1574",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs-1574-4161366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SenoresPharmace_priceRelatedfactors_4161366.png",
        "date": "2026-08-19 11:36:32",
        "description": "With a remarkable surge to Rs 1574 on 19 Aug 2026, Senores Pharmaceuticals Ltd has not only reached a fresh 52-week high but also demonstrated a powerful alignment of technical indicators that underpin its current momentum."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,564.80 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-4161344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SenoresPharmace_priceRelatedfactors_4161344.png",
        "date": "2026-08-19 11:14:45",
        "description": "Extending its remarkable rally, Senores Pharmaceuticals Ltd surged 1.74% on 19 Aug 2026 to close at Rs 1,564.80, marking a fresh all-time high. This move comes amid broad-based strength across multiple timeframes, with the stock outperforming the Sensex by over 2 percentage points on the day."
      }
    ],
    "total": 303,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Successful Completion Of USFDA Inspection",
      "datetime": "11-Sep-2026",
      "details": "We are pleased to announce that the USFDA has successfully completed its inspection at the manufacturing facility of Apnar Pharma Private Limited",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "09-Sep-2026",
      "details": "We are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Sep-2026",
      "details": "We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Senores Pharmaceuticals Falls 3.73%: Mixed Technicals and Valuation Concerns Shape Weekly Trend

2026-09-05 10:01:35

Key Events This Week

31 Aug: Stock opens at Rs.1,433.05, down 3.33% amid broad market weakness

1 Sep: MarketsMOJO downgrades Senores Pharmaceuticals to Hold

2 Sep: Mixed technical signals emerge despite 1.43% intraday gain

4 Sep: Week closes at Rs.1,427.10, down 0.37% on final trading day

stock-recommendationAnnouncement

Successful Completion Of USFDA Inspection

11-Sep-2026 | Source : BSE

We are pleased to announce that the USFDA has successfully completed its inspection at the manufacturing facility of Apnar Pharma Private Limited

Reg. 34 (1) Annual Report.

09-Sep-2026 | Source : BSE

We are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Sep-2026 | Source : BSE

We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available